If a supplied lot fails agreed specifications, we’ll replace it at no cost or refund its purchase price in full.
Quality test failed? Free replacement or full refund.
Off-spec? Free replacement or full refund.
FDA PCAC reviews 7 peptides for the 503A bulks list (BPC-157, KPV, TB-500, MOTs-C, Emideltide, Semax, Epitalon). Read our compounder's decision tree. Read our briefing →
FDA PCAC reviews 7 peptides for the 503A bulks list in July. Read →
FDA PCAC: 7 peptides under review. Read →
Metastin (45-54) · HPG-axis research peptide
Overview
Kisspeptin-10 (KP-10) is a member of the neuropeptide family encoded by the KISS1 gene — the 10-amino-acid active C-terminal fragment of the 145-amino-acid kisspeptin precursor protein, also known as Metastin (45-54). Regarded as a "master regulator" of the reproductive system, KP-10 is the endogenous ligand for hypothalamic GnRH neurons and is essential for the onset of puberty, fertility, and reproductive function. Current research is exploring its therapeutic potential in infertility, low sexual desire, and reproductive disorders. Vialdyne releases Kisspeptin-10 as a lyophilized decapeptide (linear) against a ≥99.0% HPLC main-peak specification, with a batch-specific Certificate of Analysis covering RP-HPLC purity and mass-spec identity; water content, residual solvents and endotoxin are available on request and listed on the COA when tested. Sequence / identity confirmation is documented on the released lot.
Applications & buyer fit
GH-axis peptides ship to two main buyer types: compounding pharmacies dispensing under physician supervision, and research labs studying somatotropic-axis pharmacology. Pharmacies typically want sterile-filled vials with the full release packet (sterility, endotoxin, CCI); labs typically want loose-format lyophilized powder with sequence verification. Blends (the CJC-1295 / Ipamorelin combination is the canonical example) are usually co-lyophilized rather than solution-mixed for potency stability.
Sourced for
Buyer fit
Documentation that ships
Procurement note: For sterile-filled vials, confirm whether sterility, endotoxin, and CCI are included in the agreed release packet. For loose lyophilized powder, request the batch COA and separately scope any sequence-level evidence required by the buyer's written procedure.
Primary buyer fit: academic and contract research laboratories.
Specifications
Nasal spray listing · US inventory
Kisspeptin-10 is also listed in this catalog as a nasal spray solution.

Batch COAs and test reports
Each picture is a low-resolution preview of a report's first page, with batch and report numbers covered. For the full, clear report, ask our sales team, naming the product and strength.
Batch COAKisspeptin-10 5 mg
HPLC purity · MS identity
Batch COA
Full, clear copy from sales
Batch COAKisspeptin-10 10 mg
HPLC purity · MS identity
Batch COA
Full, clear copy from sales
Independent test fails? Full refund. How it works
Browse all COAs and reportsRegulatory note
Research-use-only reference material; not for human or veterinary use.
Selected literature
Frequently asked questions
A defensible qualification packet lists identity by mass spectrometry against the theoretical mass of the C-terminal decapeptide, purity by RP-HPLC with an area-percent acceptance limit, and confirmation of the intact RFamide C-terminus since that motif governs GPR54 binding. Because Kisspeptin-10 is produced by solid-phase synthesis rather than fragment processing, the impurity profile is dominated by synthesis-related species, so the COA should report a related-substances profile alongside net peptide content, counterion identity, water content, and residual solvents. Endotoxin and microbial limits complete the release file for a compounding-oriented buyer.
The lyophilized solid is the stable form and should be held desiccated and cold, with the sealed vial equilibrated to room temperature before opening to prevent condensation onto hygroscopic powder. The net-peptide value on the certificate, not gross vial weight, is the correct basis for calculating reconstitution volume. In solution the decapeptide is far less stable than in the solid state, so working aliquots should be prepared and either used promptly or frozen once, avoiding repeated freeze-thaw. Documenting reconstitution diluent, concentration, and date supports traceability back to the released batch.
Yes. Kisspeptin-10 is listed as a nasal spray solution (10 mg), filled in 10 mL or 20 mL bottles, with an MOQ of 10 bottles per content and fill. It is dispatched within the United States from US inventory; send an inquiry for current availability.
Send any vial from your order to an independent laboratory of your choice. If the report shows the product does not meet the specification on its COA — purity below the stated minimum, or an identity that does not match — share the report with our sales team and we refund that product in full.